{"protocolSection":{"identificationModule":{"nctId":"NCT05810844","orgStudyIdInfo":{"id":"DPT/Batch-Fall18/522"},"organization":{"fullName":"Superior University","class":"OTHER"},"briefTitle":"Comparison Of Effects of MRP Vs NDT For Balance and Gait in Chronic Ischemic Stroke Patients RCT","officialTitle":"Comparison Of Effects of Motor Relearning Program (MRP) Versus Neuro Development Treatment (NDT) For Balance and Gait in Chronic Ischemic Stroke Patients: A Randomized Clinical Trial"},"statusModule":{"statusVerifiedDate":"2023-03","overallStatus":"NOT_YET_RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-04-01","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2023-06-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2023-08-31","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-03-15","studyFirstSubmitQcDate":"2023-03-31","studyFirstPostDateStruct":{"date":"2023-04-12","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-03-31","lastUpdatePostDateStruct":{"date":"2023-04-12","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Muhammad Naveed Babur","investigatorTitle":"Principal Investigator","investigatorAffiliation":"Superior University"},"leadSponsor":{"name":"Superior University","class":"OTHER"}},"oversightModule":{"oversightHasDmc":true,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"To determine the comparison between effects of Motor Relearning Program (MRP) and Neuro-Development Treatment (NDT) on balance and gait in chronic ischemic stroke patients."},"conditionsModule":{"conditions":["Stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"HEALTH_SERVICES_RESEARCH","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":40,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Motor Relearning Program (MRP)","type":"EXPERIMENTAL","interventionNames":["Diagnostic Test: Motor Relearning Program (MRP)"]},{"label":"Neuro Development Treatment (NDT)","type":"EXPERIMENTAL","interventionNames":["Diagnostic Test: Neuro Development Treatment (NDT)"]}],"interventions":[{"type":"DIAGNOSTIC_TEST","name":"Motor Relearning Program (MRP)","description":"MRP technique with a conventional physiotherapy treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke","armGroupLabels":["Motor Relearning Program (MRP)"]},{"type":"DIAGNOSTIC_TEST","name":"Neuro Development Treatment (NDT)","description":"Neuro-Development Treatment NDT as well as conventional treatment. Conventional physiotherapy treatment will help to reduce the functional impairments in chronic ischemic stroke patients","armGroupLabels":["Neuro Development Treatment (NDT)"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Effects of Motor Relearning Program Techinique, Neuro Development Treatment Techinique","timeFrame":"6 Months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. Chronic ischemic stroke Patients more than 6 months. (55)\n2. Patient with good cognitive status minimum 20 or greater out of 30 in Mini mental state examinations.(56)\n3. Age between 45-65 years.(57)\n4. Patient with limb spasticity equal to 2 or less than 2 on Modified Ashworth scale.(56)\n5. Both male and female patients.(58)\n\nExclusion Criteria:\n\n1. History of neurologic disease(59, 60)\n2. History of lower limb fracture.(61)\n3. History of spinal cord fracture.(61)\n4. Patient with skin discoloration, skin ulcers and skin allergy.(62)\n5. Patients with a history of the recurrent stroke. (63)\n6. Patients with any peripheral vascular disease.(60)","healthyVolunteers":false,"sex":"ALL","minimumAge":"45 Years","maximumAge":"65 Years","stdAges":["ADULT","OLDER_ADULT"]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000020521","term":"Stroke"},{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","asFound":"Stroke","relevance":"HIGH"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T1303","name":"Chronic Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}